Development of a Chlamydia trachomatis vaccine for urogenital infections: novel tools and new strategies point to bright future prospects
Introduction: The "cloaked" bacterial pathogen that is Chlamydia trachomatis continues to cause sexually transmitted infections (STIs) that adversely affect the health and well-being of children, adolescents and adults globally. The reproductive disease sequelae follow unresolved or untrea...
Saved in:
Main Authors: | Louise M Hafner (Author), Peter Timms (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chlamydia trachomatis Genotypes and the Swedish New Variant among Urogenital Chlamydia trachomatis Strains in Finland
by: Suvi Niemi, et al.
Published: (2011) -
Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis
by: Farnaz Mohammadzadeh, et al.
Published: (2019) -
CORRELATIONS BETWEEN CONTEMPORARY METHODS IN THE DIAGNOSIS OF CHLAMYDIA TRACHOMATIS UROGENITAL INFECTIONS.
by: Ilko Bakardzhiev, et al.
Published: (2011) -
Azithromycin versus doxycycline for the treatment of urogenital Chlamydia trachomatis infection-a retrospective study
by: Ligang YANG, et al.
Published: (2021) -
Chlamydia trachomatis Vaccine Research through the Years
by: Katelijn Schautteet, et al.
Published: (2011)